Long-term weight gain after initiating combination antiretroviral therapy in treatment-naïve Asian people living with human immunodeficiency virus

Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV

(2021) Sung-Hsi Huang et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Outcomes associated with treatment change from tenofovir disoproxil fumarate to tenofovir alafenamide in HIV‐1‐infected patients: a real‐world study in Japan

(2021) Naoki Kanda et al.   HIV MEDICINE

Weight gain before and after switch from TDF to TAF in a U.S. cohort study

(2021) Patrick WG Mallon et al.   Journal of the International AIDS Society

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

(2020) Kassem Bourgi et al.   Journal of the International AIDS Society

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials

(2020) Chloe Orkin et al.   Lancet HIV

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

(2020) L Ryom et al.   HIV MEDICINE

Greater Weight Gain in Treatment Naïve Persons Starting Dolutegravir-Based Antiretroviral Therapy

(2019) Kassem Bourgi et al.   CLINICAL INFECTIOUS DISEASES

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

(2019) Paul E Sax et al.   CLINICAL INFECTIOUS DISEASES

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir

(2019) Leonardo Calza et al.   INFECTION

Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide

(2019) Po-Hsien Kuo et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals

(2018) Rebecca Begley et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015–2017

(2018) Mario Gomez et al.   INFECTION

The Impact of Weight Gain During HIV Treatment on Risk of Pre-diabetes, Diabetes Mellitus, Cardiovascular Disease, and Mortality

(2018) Shejil Kumar et al.   Frontiers in Endocrinology

The HIV care cascade: Japanese perspectives

(2017) Aikichi Iwamoto et al.   PLoS One

Weight Gain: A Possible Side Effect of All Antiretrovirals

(2017) Lucia Taramasso et al.   Open Forum Infectious Diseases

Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada

(2016) John R. Koethe et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals

(2016) Melissa Herrin et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation

(2015) Fred R. Sattler et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Should the dose of tenofovir be reduced to 200-250 mg/day, when combined with protease inhibitors?

(2014) Andrew Hill et al.   Journal of the International AIDS Society

Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada

(2013) Hasina Samji et al.   PLoS One

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

(2011) Jacqueline Capeau et al.   AIDS

HIV infection and the risk of diabetes mellitus

(2009) Adeel A Butt et al.   AIDS